Procter & Gamble Hygiene and Health Care Limited — Important, 17-08-2026: Updates
17-08-2026 | 06:59 pm
17-08-2026 | 06:59 pm
Company reported FY26 revenue of ₹4,290 Cr and PAT of ₹857 Cr (up 19%). Product innovation in Whisper & Vicks drove growth. A shift to contract manufacturing for Vicks up to ₹1,000 Cr/year is approved. Ms. Srividya Srinivasan is appointed Whole-time Director & CFO.
No comments yet. Be the first to comment!
All announcements from Procter & Gamble Hygiene and Health Care Limited
